| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |